Stock listing
NASDAQ:ARMO Armo Biosciences Inc. Stock
Follow Armo Biosciences Inc. into a list and get an email when it puts out news.
Last close · NASDAQ:ARMO
$49.98 USD
Close on Jun 21, 2018 · No longer trades
- Lowest – highest close
- $25.68 – $54.34 USDSince Jan 26, 2018 · lowest Apr 18, 2018 · highest Feb 20, 2018
Delisted NASDAQ:ARMO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ARMO
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Beth C Seidenberg Other companies: Latigo Biotherapeutics, Inc. (Director · Since at least Aug 6, 2026); Kyverna Therapeutics, Inc. (Director · Since at least Feb 7, 2024); Sagimet Biosciences Inc. - Series A (Director · Since at least Jul 13, 2023); Vera Therapeutics, Inc. (Director · Since at least May 13, 2021); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Progyny, Inc. (Director · Oct 24, 2019 – May 23, 2024 · Past); Atara Biotherapeutics, Inc. (Director · Oct 15, 2014 – May 31, 2023 · Past); Epizyme Inc (Director · May 30, 2013 – Jun 30, 2019 · Past); Tesaro Inc (Director · Jun 27, 2012 – Jan 22, 2019 · Past) | Director · Jan 25, 2018 – Jun 22, 2018 · Past |
| Herb Cross Other companies: Jasper Therapeutics, Inc. (Chief Financial Officer · Since at least Sep 22, 2023); Apexigen Inc. (Director · Jul 29, 2022 – Aug 23, 2023 · Past); Atreca Inc (Chief Financial Officer · Jun 19, 2019 – Aug 2, 2023 · Past); Humanigen Inc (Chief Financial Officer · Oct 22, 2013 – Nov 9, 2015 · Past); Affymax Inc (Chief Financial Officer · Nov 15, 2010 – Jan 30, 2013 · Past); Facet Biotech Corp (VP of Finance · Dec 9, 2008 – Apr 21, 2010 · Past); PDL BioPharma Inc (Corp Controller/Prin Acctg Off · Jun 20, 2007 – Sep 15, 2008 · Past); Neoforma Inc (VP of Finance · Dec 31, 2005 – Dec 31, 2005 · Past) | Chief Financial Officer · Jan 25, 2018 – Jun 22, 2018 · Past |
| Pierre Legault Other companies: Syndax Pharmaceuticals, Inc. (Director · Since at least Jan 4, 2017); Bicycle Therapeutics PLC (Director · May 22, 2019 – Jan 2, 2025 · Past); Urovant Sciences Ltd (Director · Sep 26, 2018 – Mar 29, 2021 · Past); NPS Pharmaceuticals Inc (Director · Nov 3, 2014 – Feb 21, 2015 · Past); NephroGenex Inc (Chief Executive Officer, Director · Feb 10, 2014 – Nov 10, 2015 · Past); Tobira Therapeutics Inc (Director · Nov 18, 2013 – Nov 1, 2016 · Past); Forest Laboratories Inc (Director · Aug 15, 2013 – Jul 1, 2014 · Past) | Director · Jan 25, 2018 – Mar 26, 2018 · Past |
| Xiangmin Cui Other companies: Nuvation Bio Inc. (Director · Since at least Apr 9, 2024); Alpine Immune Sciences Inc (Director · Jan 18, 2019 – May 18, 2024 · Past); China Biologic Products Holdings Inc (Director · Feb 4, 2010 – Jan 1, 2011 · Past) | Director · Jan 25, 2018 – Jun 22, 2018 · Past |
| Joseph Leveque Other companies: Synthorx Inc (Chief Medical Officer · Dec 6, 2018 – Jan 23, 2020 · Past) | Chief Medical Officer · Jan 25, 2018 – Jun 22, 2018 · Past |
| Naiyer Rizvi Other companies: Gritstone bio, Inc. (Director · Jun 1, 2021 – Apr 4, 2025 · Past) | Director · Jan 25, 2018 – Jun 22, 2018 · Past |
Log in to ask 6ix AI your own questions about Armo Biosciences Inc.